Literature DB >> 26164397

The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.

Yong Yang1, Xiao Zhu Zhang2, Han Seong Ng3, Jeffrey Chern Hui Fong4, Lai Heng Lee5.   

Abstract

BACKGROUND: Chronic liver disease (CLD) has been suggested to be associated with venous thromboembolism (VTE) in western populations. However, little is known about the risk effects of CLD on VTE among Asians.
OBJECTIVE: To compute the prevalence of VTE among hospitalised Asian patients, and to evaluate the pattern and scale of risk effects of CLD on VTE occurrence.
METHOD: Retrospective study of hospital discharge database from 2004 to 2011 to identify patients with VTE and CLD using International Statistical Classification of Diseases and Related Health Problems, 9th Revision, Australian Modification (ICD-9-AM) codes.
RESULTS: Of 199904 medically managed inpatients during the 8years, 1744 (0.9%) patients had VTE. Patients with CLD had significant higher prevalence of VTE (non-cirrhosis CLD 1.5%, cirrhosis 2.0%) than patients without CLD (0.8%, p<0.001). In the logistic regression analyses, non-cirrhosis CLD (odds ratio, OR 1.4, 95% CI 1.2-1.7, p<0.001) and cirrhosis (OR 1.5, 95% CI 1.2-2.0, p=0.002) were significant predictors of VTE after adjustment for age, gender, ethnicity, hospital long stayer, cancer, infectious disease, and other comorbid conditions such as diabetic mellitus, anaemia, and cardiovascular, cerebrovascular, renal and pulmonary diseases.
CONCLUSION: CLD, particular liver cirrhosis, increases the risks of VTE in hospitalised Asian patients. As CLD patients are perceived to be at risks of bleeding due to the prolonged clotting times and thrombocytopenia, the results of this study brings attention to opposite end of the haemostatic pendulum in patients with chronic liver disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ICD-9-AM; chronic liver disease; risk factor; venous thromboembolism

Mesh:

Year:  2015        PMID: 26164397     DOI: 10.1016/j.thromres.2015.06.033

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  Anticoagulation in patients with advanced liver disease: an open issue.

Authors:  Francesco Violi; Lorenzo Loffredo; Daniele Pastori
Journal:  Intern Emerg Med       Date:  2020-10-18       Impact factor: 3.397

2.  Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.

Authors:  A S Mansfield; A J Tafur; D Vulih; G L Smith; P J Harris; S P Ivy
Journal:  Thromb Res       Date:  2015-10-20       Impact factor: 3.944

3.  Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study.

Authors:  Yao Chen; Jianping Zhao; Zhanguo Zhang; Zeyang Ding; Yifa Chen; Xiaoping Chen; Wanguang Zhang
Journal:  J Hepatocell Carcinoma       Date:  2021-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.